Empresa Exalenz Bioscience Ltd. TEL AVIV STOCK EXCHANGE
Acciones
IL0011048688
Equipo médico, suministros y distribución
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 01/10/10 |
Moshe Dori
DFI | Director of Finance/CFO | - | 29/01/19 |
Eitan Blank
COO | Chief Operating Officer | 54 | 01/01/07 |
Ofer Schlesinger
CTO | Chief Tech/Sci/R&D Officer | 59 | 23/07/14 |
Ilan Ben Oren
CTO | Chief Tech/Sci/R&D Officer | 59 | 11/04/06 |
Didier Samuel
PRN | Corporate Officer/Principal | - | - |
Ari Soae
PRN | Corporate Officer/Principal | 46 | 01/01/06 |
Ilan Haikin
AUD | Comptroller/Controller/Auditor | 69 | 21/11/10 |
Gavin Doree
SAM | Sales & Marketing | 47 | 29/07/13 |
Susan Alpert
LAW | General Counsel | 78 | 01/01/11 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 04/07/16 |
Moshe Arkin
BRD | Director/Board Member | 69 | 01/01/06 |
Hanna Lerman
BRD | Director/Board Member | 51 | 16/04/15 |
Itai Arkin
BRD | Director/Board Member | 35 | 16/04/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 26 917 095 | 6 557 013 ( 24,36 %) | 0 | 24,36 % |
Información de la empresa
Meridian Bioscience Israel Ltd.
4 Ha'maayan Street
7177872, Modi'in-Maccabim-Re'ut
+
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-5,43 % | 182 mil M | |
+4,30 % | 114 mil M | |
-3,09 % | 68,38 mil M | |
+5,86 % | 52,46 mil M | |
+8,15 % | 44,25 mil M | |
+7,52 % | 43,55 mil M | |
+25,54 % | 32,69 mil M | |
+17,85 % | 26,73 mil M | |
+1,00 % | 25,79 mil M |